BEAM
Price
$21.38
Change
-$0.22 (-1.02%)
Updated
Apr 26, 6:59 PM EST
10 days until earnings call
PRME
Price
$4.42
Change
+$0.13 (+3.02%)
Updated
Apr 26, 6:59 PM EST
12 days until earnings call
Ad is loading...

Compare trend and price BEAM vs PRME

Header iconBEAM vs PRME Comparison
Open Charts BEAM vs PRMEBanner chart's image
Beam Therapeutics
Price$21.38
Change-$0.22 (-1.02%)
Volume$713.48K
CapitalizationN/A
Prime Medicine
Price$4.42
Change+$0.13 (+3.02%)
Volume$422.76K
CapitalizationN/A
View a ticker or compare two or three
BEAM vs PRME Comparison Chart

Loading...

BEAMDaily Signal changed days agoGain/Loss if shorted
 
Show more...
PRMEDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
BEAM vs. PRME commentary
Apr 27, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and PRME is a Sell.

COMPARISON
Comparison
Apr 27, 2024
Stock price -- (BEAM: $21.38 vs. PRME: $4.43)
Brand notoriety: BEAM and PRME are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 80% vs. PRME: 97%
Market capitalization -- BEAM: $1.76B vs. PRME: $530.73M
BEAM [@Biotechnology] is valued at $1.76B. PRME’s [@Biotechnology] market capitalization is $530.73M. The market cap for tickers in the [@Biotechnology] industry ranges from $556.22B to $0. The average market capitalization across the [@Biotechnology] industry is $2.54B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whilePRME’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • PRME’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than PRME.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 2 TA indicator(s) are bullish while PRME’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 2 bullish, 4 bearish.
  • PRME’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, PRME is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а -10.54% price change this week, while PRME (@Biotechnology) price change was -1.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.69%. For the same industry, the average monthly price growth was -8.16%, and the average quarterly price growth was +1262.42%.

Reported Earning Dates

BEAM is expected to report earnings on Aug 06, 2024.

PRME is expected to report earnings on May 09, 2024.

Industries' Descriptions

@Biotechnology (+1.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for BEAM with price predictions.
OPEN
A.I.dvisor published
a Summary for PRME with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
BEAM($1.76B) has a higher market cap than PRME($531M). BEAM YTD gains are higher at: -21.455 vs. PRME (-50.056).
BEAMPRMEBEAM / PRME
Capitalization1.76B531M331%
EBITDAN/AN/A-
Gain YTD-21.455-50.05643%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
BEAMPRME
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
62%
Stochastic
ODDS (%)
N/A
Bullish Trend 1 day ago
67%
Momentum
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
72%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
74%
Advances
ODDS (%)
N/A
Bullish Trend 5 days ago
64%
Declines
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 3 days ago
72%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
53%
Aroon
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
82%
View a ticker or compare two or three
Ad is loading...
BEAMDaily Signal changed days agoGain/Loss if shorted
 
Show more...
PRMEDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PLIEX28.480.49
+1.75%
Plumb Equity Institutional
MSRRX54.260.64
+1.19%
MFS Research R2
HNDRX69.920.68
+0.98%
Horizon Defined Risk Investor
GVIYX11.44-0.01
-0.09%
GuideStone Funds Value Equity Idx Instl
DHMYX25.94-0.16
-0.61%
Diamond Hill Small-Mid Cap Y

PRME and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRME has been loosely correlated with BEAM. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if PRME jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRME
1D Price
Change %
PRME100%
+2.91%
BEAM - PRME
63%
Loosely correlated
-1.02%
NTLA - PRME
61%
Loosely correlated
+3.70%
RLAY - PRME
54%
Loosely correlated
+3.49%
XNCR - PRME
53%
Loosely correlated
+3.90%
ABCL - PRME
50%
Loosely correlated
+3.58%
More